Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model
Diabetic retinopathy, an inflammatory condition, is one of the devastating complication associated with diabetes that can lead to irreversible blindness. Gentiopicroside (GP), a secoiridoid glycoside, exhibits anti-inflammatory and antioxidant activity. The investigation was carried out to explore w...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/2058739219847837 |
id |
doaj-fcb401cd714040f084c28123530a23d6 |
---|---|
record_format |
Article |
spelling |
doaj-fcb401cd714040f084c28123530a23d62020-11-25T03:24:03ZengSAGE PublishingEuropean Journal of Inflammation2058-73922019-05-011710.1177/2058739219847837Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat modelXian Zhang0En Shi1Lan Yang2Weina Fu3Feng Hu4Xisong Zhou5Department of Ophthalmology, Taipei Medical University Ningbo Medical Center, Ningbo, ChinaDepartment of Ophthalmology, Taipei Medical University Ningbo Medical Center, Ningbo, ChinaDepartment of Ophthalmology, Taipei Medical University Ningbo Medical Center, Ningbo, ChinaDepartment of Ophthalmology, Taipei Medical University Ningbo Medical Center, Ningbo, ChinaDepartment of Ophthalmology, Taipei Medical University Ningbo Medical Center, Ningbo, ChinaDepartment of Ophthalmology, Taipei Medical University Ningbo Medical Center, Ningbo, ChinaDiabetic retinopathy, an inflammatory condition, is one of the devastating complication associated with diabetes that can lead to irreversible blindness. Gentiopicroside (GP), a secoiridoid glycoside, exhibits anti-inflammatory and antioxidant activity. The investigation was carried out to explore whether GP could attenuate diabetic retinopathy in diabetic rats. Diabetes was induced by injecting streptozotocin (STZ) (65 mg/kg) intraperitoneally in 8-weeks-old male rats (200–240 g). The treatment group received GP (20, 40, 80 mg/kg) orally for a duration of 10 weeks in diabetic rats (n = 10), and the diabetic group animals received phosphate buffer solution (n = 20). Effect of GP on cell viability study was performed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Oxidative stress markers, inflammatory mediators, and angiogenic factors were quantified in the retinal tissues of diabetic animals. All data were analyzed by one-way analysis of variance (ANOVA) at P < 0.05. Cytoprotective effect of GP was observed in MTT assay. GP effectively downregulated inflammatory cytokine, nuclear factor κB (NF-κB), tumor necrosis factor-α (TNF-α), interleukin 1 beta (IL-1β), and intercellular adhesion molecules-1 (ICAM-1), and upregulated antioxidant markers glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) in the retina of diabetic rats. GP equilibrated the disturbed angiogenic factors in the diabetic retinal tissues. Results clearly indicated defensive role of GP in the treatment of diabetic retinopathy by inhibition of NF-κB and oxidative stress.https://doi.org/10.1177/2058739219847837 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xian Zhang En Shi Lan Yang Weina Fu Feng Hu Xisong Zhou |
spellingShingle |
Xian Zhang En Shi Lan Yang Weina Fu Feng Hu Xisong Zhou Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model European Journal of Inflammation |
author_facet |
Xian Zhang En Shi Lan Yang Weina Fu Feng Hu Xisong Zhou |
author_sort |
Xian Zhang |
title |
Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model |
title_short |
Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model |
title_full |
Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model |
title_fullStr |
Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model |
title_full_unstemmed |
Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model |
title_sort |
gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and nf-κb activation in rat model |
publisher |
SAGE Publishing |
series |
European Journal of Inflammation |
issn |
2058-7392 |
publishDate |
2019-05-01 |
description |
Diabetic retinopathy, an inflammatory condition, is one of the devastating complication associated with diabetes that can lead to irreversible blindness. Gentiopicroside (GP), a secoiridoid glycoside, exhibits anti-inflammatory and antioxidant activity. The investigation was carried out to explore whether GP could attenuate diabetic retinopathy in diabetic rats. Diabetes was induced by injecting streptozotocin (STZ) (65 mg/kg) intraperitoneally in 8-weeks-old male rats (200–240 g). The treatment group received GP (20, 40, 80 mg/kg) orally for a duration of 10 weeks in diabetic rats (n = 10), and the diabetic group animals received phosphate buffer solution (n = 20). Effect of GP on cell viability study was performed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Oxidative stress markers, inflammatory mediators, and angiogenic factors were quantified in the retinal tissues of diabetic animals. All data were analyzed by one-way analysis of variance (ANOVA) at P < 0.05. Cytoprotective effect of GP was observed in MTT assay. GP effectively downregulated inflammatory cytokine, nuclear factor κB (NF-κB), tumor necrosis factor-α (TNF-α), interleukin 1 beta (IL-1β), and intercellular adhesion molecules-1 (ICAM-1), and upregulated antioxidant markers glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) in the retina of diabetic rats. GP equilibrated the disturbed angiogenic factors in the diabetic retinal tissues. Results clearly indicated defensive role of GP in the treatment of diabetic retinopathy by inhibition of NF-κB and oxidative stress. |
url |
https://doi.org/10.1177/2058739219847837 |
work_keys_str_mv |
AT xianzhang gentiopicrosideattenuatesdiabeticretinopathybyinhibitinginflammationoxidativestressandnfkbactivationinratmodel AT enshi gentiopicrosideattenuatesdiabeticretinopathybyinhibitinginflammationoxidativestressandnfkbactivationinratmodel AT lanyang gentiopicrosideattenuatesdiabeticretinopathybyinhibitinginflammationoxidativestressandnfkbactivationinratmodel AT weinafu gentiopicrosideattenuatesdiabeticretinopathybyinhibitinginflammationoxidativestressandnfkbactivationinratmodel AT fenghu gentiopicrosideattenuatesdiabeticretinopathybyinhibitinginflammationoxidativestressandnfkbactivationinratmodel AT xisongzhou gentiopicrosideattenuatesdiabeticretinopathybyinhibitinginflammationoxidativestressandnfkbactivationinratmodel |
_version_ |
1724603649984823296 |